Skip to main content
. 2019 Mar 3;9(3):e024476. doi: 10.1136/bmjopen-2018-024476

Figure 2.

Figure 2

Evolution of cardiometabolic disease status during follow-up. Note: *Crude prevalence. CVD, cardiovascular disease; DM, diabetes mellitus; HT, hypertension.